There’s currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...

Eli Lilly's Kisunla was approved in the U.S. for Alzheimer's last year, but now advisers to the European Medicines Agency say ...

The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

Obesity and diabetes, more common in recent decades, could lead to more dementia, but much touted new drugs that reduce them ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

GSK, led by boss Emma Walmsley (pictured), is using the data of 1.4m adults aged 65 and 66 to examine the impact of its ...